Hélène Haegel

Company: Roche

Job title: Principal Scientist, Immunosafety Pharmaceutical Sciences

Seminars:

9:30AM Exploring Novel Approaches to Mitigate Gene Therapy Immunogenicity 9:30 am

• What are the latest advances in immunosuppression protocols to mitigate immune responses to the AAV vector and the transgene product? • Discuss the risks and benefits of these strategies, including patient safety considerations and immune system recovery • Sharing examples demonstrating success or challenges with immunosuppressive treatmentsRead more

day: Conference Day 2